glycopyrrolate has been researched along with Hyperhidrosis in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (3.08) | 18.2507 |
| 2000's | 15 (23.08) | 29.6817 |
| 2010's | 29 (44.62) | 24.3611 |
| 2020's | 19 (29.23) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, C; Fujimoto, T; Ogawa, S; Wanatabe, S; Yokozeki, H | 1 |
| Cantor, A; Moisiuc, A; Pecha, JD; Yen, KG | 1 |
| Benedict, D; Pariser, D; Rivera, E | 1 |
| Khashaba, SA; Nofal, E; Salem, S | 1 |
| Eisenstein, K; Sandhu, M | 1 |
| Abels, C; Berger, B; Heimstaedt-Muskett, S; Kilic, A; Litzka, L; Masur, C; Reich, H; Schramm, K; Schulze Zur Wiesche, E; Szeimies, RM | 1 |
| Buchanan, J; Green, HH; Matsler, N; Ray, L | 1 |
| Arnold, MJ; O'Connor, C | 1 |
| Lamb, YN | 1 |
| Baneke, A; Paul, B; Radotra, A | 1 |
| Arnold, A; Assam, JH; Bonelli, L; Lee, AG; Pashaei-Marandi, A | 1 |
| Figenshau, K; Rajpara, A; Siscos, SM | 1 |
| Baumann, L; Bhatia, N; Chadha, D; Cohen, J; DuBois, J; Green, L; Kirsch, B; Liu, PY; Pariser, D; Smith, S; Walker, P | 1 |
| Cather, J; Drew, J; Glaser, DA; Gopalan, R; Green, L; Hebert, AA; Hull, C; Pariser, DM | 1 |
| Kaur, M; Patra, S; Sharma, VK | 1 |
| Curnyn, KM; Gulati, S; Kaufman, AR | 1 |
| Del Boz, J; García-Souto, F; Polo-Padillo, J; Rivas-Ruiz, F | 1 |
| Del Boz, J; Garcia-Souto, F; Polo-Padillo, J | 1 |
| Caserta, F; Hofland, H; Lenn, J | 1 |
| Drew, J; Lain, EL; Mamelok, RD; Mould, DR; Pariser, DM | 1 |
| Abels, C; Heimstaedt-Muskett, S; Jourdan, C; Kilic, A; Knie, U; Masur, C; Reich, H; Schramm, K; Soeberdt, M; Szeimies, RM | 1 |
| Michael, T; Paul, C | 1 |
| Fischer, R; Liu, D; Prouty, ME | 1 |
| Drew, J; Glaser, DA; Green, L; Hebert, AA; Mamelok, R; Nast, A; Pariser, DM; Quiring, J; Werschler, WP | 1 |
| Drew, J; Glaser, DA; Gopalan, R; Hebert, AA; Pariser, DM; Quiring, J | 1 |
| Drew, J; Forsha, DW; Glaser, DA; Gopalan, R; Green, L; Hebert, AA; Pariser, DM; Werschler, WP | 1 |
| Abels, C; Chabicovsky, M; Kilic, A; Masur, C; Soeberdt, M; Winkler, S | 1 |
| Coleman, K; Limmer, AL; Mui, UN; Nwannunu, CE; Patel, RR; Shah, R; Tyring, SK | 1 |
| Drew, J; Glaser, DA; Green, L; Hebert, AA; Mamelok, RD; Nast, A; Pariser, DM; Quiring, J; Werschler, WP | 1 |
| Abels, C; Kilic, A; Knie, U; Masur, C; Soeberdt, M | 1 |
| Micieli, JA; Micieli, R | 1 |
| Mago, R | 1 |
| Burns, C; Kavanagh, G; Mackenzie, A | 1 |
| Hale, DR; Kavanagh, GM; MacKenzie, AI | 1 |
| Choi, HG; Hong, CK; Hyun, MY; Kim, BJ; Kim, MN; Lee, Y; Li, K; Park, KY; Seo, SJ; Son, IP | 1 |
| Coleman, MJ; Tomsak, RL | 1 |
| del Boz, J | 1 |
| Dumitrescu, TP; Gobburu, J; Mehrotra, S; Schmith, VD | 1 |
| Baker, DM; Nicholas, R; Quddus, A | 1 |
| Gesuwan, K; Hynes, CF; Margolis, M; Marshall, MB; Seevaratnam, S | 1 |
| Baker, DM | 1 |
| de Troya-Martín, M; Del Boz, J; Millán-Cayetano, JF; Rivas-Ruiz, F | 1 |
| Callejas, MA; Grimalt, R | 1 |
| Callejas Pérez, MA; Cladellas Gutiérrez, E; Grimalt Santacana, R | 1 |
| Chia, HY; Chong, WS; Tan, AS; Tey, HL | 1 |
| Walling, HW | 1 |
| Chamlin, SL; Mancini, AJ; Paller, AS; Shah, PR; Silverio, AM; Wagner, A | 1 |
| Alsharqi, A; Wilson, NJ | 1 |
| Johnson, C; Smereck, J | 1 |
| Blackwell, TA; Luh, JY | 1 |
| Dolianitis, C; Kelly, J; Scarff, CE; Sinclair, R | 1 |
| Holt, PJ; Lewis, VJ | 1 |
| Aldridge, RD; Burns, C; Kavanagh, GM | 1 |
| Beck, MH; Madan, V | 1 |
| Choudhary, A; Izadi, S; Newman, W | 1 |
| Haworth, AE; Sega-Hall, GM; Smith, P | 1 |
| Bajaj, V; Haniffa, M; Reynolds, NJ | 1 |
| Bajaj, V; Langtry, JA | 1 |
| Alkali, AS; Newman, WD; Panting, KJ; Sharpe, GR | 1 |
| Lefrandt, JD; Maurer, JM | 1 |
| Kil, HK; Kim, WO; Yoon, DM; Yoon, KB | 1 |
| Highet, AS; Seukeran, DC | 1 |
| Catterall, M; Klaber, M | 1 |
| Li, WM; Lin, GS; Shen, JL | 1 |
8 review(s) available for glycopyrrolate and Hyperhidrosis
| Article | Year |
|---|---|
Intradermal Botulinum Toxin A Injection Versus Topical 2% Glycopyrrolate for the Treatment of Primary Facial Hyperhidrosis: A Pilot Study and Review of Literature.
Topics: Botulinum Toxins, Type A; Glycopyrrolate; Humans; Hyperhidrosis; Injections, Intradermal; Pilot Projects; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Glycopyrronium (Qbrexza) Topical Wipes for Hyperhidrosis.
Topics: Administration, Cutaneous; Cholinergic Antagonists; Glycopyrrolate; Humans; Hyperhidrosis | 2019 |
Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use.
Topics: Administration, Topical; Axilla; Glycopyrrolate; Humans; Hyperhidrosis | 2019 |
Qbrexza - A glycopyrronium cloth for axillary hyperhidrosis.
Topics: Administration, Topical; Axilla; Cholinergic Antagonists; Glycopyrrolate; Humans; Hyperhidrosis; Randomized Controlled Trials as Topic | 2019 |
Pharmacology, toxicology and clinical safety of glycopyrrolate.
Topics: Administration, Inhalation; Administration, Oral; Administration, Topical; Animals; Carcinogenicity Tests; Cholinergic Antagonists; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Molecular Structure; Mutagenicity Tests; Pulmonary Disease, Chronic Obstructive; Reproduction | 2019 |
Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis
Topics: Administration, Cutaneous; Cholinergic Antagonists; Clinical Trials as Topic; Glycopyrrolate; Humans; Hyperhidrosis | 2019 |
Systemic treatment of hyperhidrosis.
Topics: Antihypertensive Agents; Cholinergic Antagonists; Clinical Trials as Topic; Disease Management; Evidence-Based Medicine; Glycopyrrolate; Humans; Hyperhidrosis; Meta-Analysis as Topic; Off-Label Use; Psychotropic Drugs | 2015 |
Treatment of Primary Craniofacial Hyperhidrosis: A Systematic Review.
Topics: Botulinum Toxins, Type A; Cholinergic Antagonists; Facial Dermatoses; Ganglionectomy; Glycopyrrolate; Head; Humans; Hyperhidrosis; Mandelic Acids; Neck; Neuromuscular Agents | 2015 |
16 trial(s) available for glycopyrrolate and Hyperhidrosis
| Article | Year |
|---|---|
Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double-blind, vehicle-controlled study.
Topics: Axilla; Double-Blind Method; Glycopyrrolate; Humans; Hyperhidrosis; Japan; Treatment Outcome | 2022 |
Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial.
Topics: Double-Blind Method; Emollients; Glycopyrrolate; Humans; Hyperhidrosis; Quality of Life; Treatment Outcome | 2023 |
Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial.
Topics: Adult; Axilla; Cholinergic Antagonists; Double-Blind Method; Female; Gels; Glycopyrrolate; Humans; Hyperhidrosis; Male; Middle Aged; Severity of Illness Index; Sweat; Vision Disorders; Xerostomia; Young Adult | 2020 |
Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.
Topics: Axilla; Child; Cholinergic Antagonists; Double-Blind Method; Glycopyrrolate; Humans; Hyperhidrosis; Treatment Outcome | 2020 |
Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
Topics: Adolescent; Adult; Aged; Axilla; Child; Cholinergic Antagonists; Glycopyrrolate; Humans; Hyperhidrosis; Middle Aged; Muscarinic Antagonists; Young Adult | 2021 |
A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.
Topics: Axilla; Double-Blind Method; Glycopyrrolate; Humans; Hyperhidrosis; Quality of Life; Sweating; Treatment Outcome | 2021 |
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
Topics: Administration, Topical; Adult; Axilla; Cholinergic Antagonists; Double-Blind Method; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male | 2019 |
Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
Topics: Adolescent; Adult; Axilla; Child; Cholinergic Antagonists; Double-Blind Method; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Middle Aged; Patient Reported Outcome Measures; Quality of Life; Severity of Illness Index; Sweating; Treatment Outcome; Young Adult | 2019 |
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
Topics: Administration, Topical; Adolescent; Adult; Aged; Axilla; Child; Female; Germany; Glycopyrrolate; Humans; Hyperhidrosis; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome; United States; Young Adult | 2019 |
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
Topics: Administration, Cutaneous; Adolescent; Adult; Axilla; Child; Cholinergic Antagonists; Double-Blind Method; Female; Follow-Up Studies; Glycopyrrolate; Humans; Hyperhidrosis; Male; Quality of Life; Severity of Illness Index; Sweating; Treatment Outcome; Young Adult | 2019 |
Safety and efficacy of topical formulations containing 0·5, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double-blind, placebo-controlled study.
Topics: Axilla; Double-Blind Method; Glycopyrrolate; Humans; Hyperhidrosis; Treatment Outcome | 2020 |
Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double-blinded, placebo-controlled, split-face study.
Topics: Administration, Topical; Double-Blind Method; Face; Glycopyrrolate; Humans; Hyperhidrosis; Placebos | 2015 |
Pharmacometrics-guided drug development of antihyperhidrosis agents.
Topics: Administration, Topical; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Middle Aged; Models, Biological; Muscarinic Antagonists; Sample Size; Severity of Illness Index; Sweating; Young Adult | 2015 |
[Topical glycopyrrolate in craniofacial hyperhidrosis].
Topics: Administration, Topical; Face; Glycopyrrolate; Humans; Hyperhidrosis; Scalp | 2008 |
Iontophoresis with glycopyrrolate for the treatment of palmoplantar hyperhidrosis.
Topics: Adolescent; Adult; Child; Female; Glycopyrrolate; Humans; Hyperhidrosis; Iontophoresis; Male; Middle Aged; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Water | 2004 |
A new strategy of iontophoresis for hyperhidrosis.
Topics: Aluminum; Aluminum Chloride; Aluminum Compounds; Chlorides; Double-Blind Method; Female; Glycopyrrolate; Humans; Hyperhidrosis; Iontophoresis; Male; Seasons; Time Factors | 1990 |
41 other study(ies) available for glycopyrrolate and Hyperhidrosis
| Article | Year |
|---|---|
Anisocoria secondary to antiperspirant wipes in a pediatric population: a case series.
Topics: Adolescent; Anisocoria; Antiperspirants; Child; Glycopyrrolate; Humans; Hyperhidrosis; Mydriasis | 2022 |
Open-Label Cohort Study to Evaluate Efficacy and Safety of Application of Glycopyrronium Cloth, 2.4% for Palmar Hyperhidrosis.
Topics: Axilla; Cohort Studies; Glycopyrrolate; Hand; Humans; Hyperhidrosis; Quality of Life; Treatment Outcome | 2022 |
Mydriasis and anisocoria in a pediatric hyperhidrosis patient with interesting findings in the family cat.
Topics: Animals; Anisocoria; Cats; Female; Glycopyrrolate; Humans; Hyperhidrosis; Muscarinic Antagonists; Mydriasis | 2023 |
Urinary retention and mydriasis secondary to topical glycopyrronium for axillary hyperhidrosis.
Topics: Adult; Drug-Related Side Effects and Adverse Reactions; Female; Glycopyrrolate; Humans; Hyperhidrosis; Mydriasis; Urinary Retention; Young Adult | 2023 |
Mydriasis secondary to use of glycopyrrolate cream.
Topics: Administration, Cutaneous; Anisocoria; Female; Glycopyrrolate; Humans; Hyperhidrosis; Middle Aged; Muscarinic Antagonists; Mydriasis; Skin Cream | 2019 |
Reversible anisocoria due to inadvertent ocular exposure to topical anticholinergic treatment for primary axillary hyperhidrosis.
Topics: Administration, Topical; Adult; Anisocoria; Axilla; Cholinergic Antagonists; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Vision Disorders | 2019 |
Use of gloves when applying topical glycopyrronium for treatment of primary axillary hyperhidrosis.
Topics: Axilla; Eye Diseases; Gloves, Protective; Glycopyrrolate; Hand Disinfection; Humans; Hyperhidrosis; Muscarinic Antagonists; Self Care | 2020 |
Stepwise treatment of primary focal hyperhidrosis with aluminum chloride hexahydrate lotion (20%) and oral glycopyrrolate: a retrospective study from a tertiary care center.
Topics: Aluminum Chloride; Glycopyrrolate; Humans; Hyperhidrosis; Male; Retrospective Studies; Tertiary Care Centers | 2020 |
Pharmacologic anisocoria secondary to topical glycopyrronium for axillary hyperhidrosis: an emerging clinical presentation.
Topics: Anisocoria; Axilla; Cholinergic Antagonists; Glycopyrrolate; Humans; Hyperhidrosis | 2020 |
Survival study of treatment adherence by patients given oral glycopyrrolate for hyperhidrosis following treatment failure with oral oxybutynin.
Topics: Adult; Female; Glycopyrrolate; Humans; Hyperhidrosis; Mandelic Acids; Muscarinic Antagonists; Prospective Studies; Treatment Adherence and Compliance; Treatment Failure; Treatment Outcome | 2020 |
Adjusting oral glycopyrrolate medication for hyperhidrosis to reflect seasonal temperature variations.
Topics: Administration, Oral; Glycopyrrolate; Humans; Hyperhidrosis; Muscarinic Antagonists; Prospective Studies; Seasons; Temperature; Treatment Outcome | 2020 |
Variables Affecting Delivery of Glycopyrronium Tosylate Through Human Skin In Vitro.
Topics: Abdominal Wall; Administration, Cutaneous; Axilla; Cholinergic Antagonists; Chromatography, High Pressure Liquid; Foot; Glycopyrrolate; Hand; Humans; Hyperhidrosis; Skin; Skin Absorption; Tandem Mass Spectrometry; Time Factors | 2020 |
A new medication, a new toxidrome - A case report of anticholinergic wipe toxicity due to improper medication use.
Topics: Administration, Topical; Adolescent; Axilla; Cholinergic Antagonists; Emergency Service, Hospital; Female; Glycopyrrolate; Hoarseness; Humans; Hyperhidrosis; Mydriasis; Urinary Incontinence | 2021 |
Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment.
Topics: Adult; Deprescriptions; Female; Glycopyrrolate; Humans; Hyperhidrosis; Mandelic Acids; Muscarinic Antagonists; Treatment Outcome | 2016 |
Dilated Pupil in a Patient With Hyperhidrosis.
Topics: Adult; Anisocoria; Diagnosis, Differential; Female; Glycopyrrolate; Humans; Hyperhidrosis; Muscarinic Antagonists; Mydriasis; Pupil | 2019 |
Glycopyrrolate for antidepressant-associated excessive sweating.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Female; Glycopyrrolate; Humans; Hyperhidrosis; Muscarinic Antagonists | 2013 |
Topical glycopyrrolate for axillary hyperhidrosis.
Topics: Administration, Cutaneous; Adolescent; Adult; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Muscarinic Antagonists; Young Adult | 2013 |
Our experience of glycopyrrolate 2% cream for axillary hyperhidrosis.
Topics: Administration, Cutaneous; Adolescent; Adult; Axilla; Drug Administration Schedule; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Muscarinic Antagonists; Ointments; Patient Satisfaction; Treatment Outcome; Young Adult | 2014 |
A 15-year-old girl with variable anisocoria.
Topics: Adolescent; Anisocoria; Female; Glycopyrrolate; Humans; Hyperhidrosis; Muscarinic Antagonists | 2014 |
The efficacy of oral anticholinergics for sympathetic overactivity in a thoracic surgery clinic.
Topics: Administration, Oral; Adult; Algorithms; Choice Behavior; Cholinergic Antagonists; Critical Pathways; Female; Flushing; Glycopyrrolate; Humans; Hyperhidrosis; Male; Outpatient Clinics, Hospital; Patient Acceptance of Health Care; Retrospective Studies; Sweating; Sympathetic Nervous System; Time Factors; Treatment Outcome; Young Adult | 2016 |
Topical glycopyrrolate reduces axillary hyperhidrosis.
Topics: Adolescent; Adult; Aged; Axilla; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Middle Aged | 2016 |
Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Drug Administration Schedule; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Prospective Studies; Treatment Outcome; Young Adult | 2017 |
[A medical alternative for the treatment of localized hyperhidrosis].
Topics: Administration, Topical; Adult; Glycopyrrolate; Humans; Hyperhidrosis; Muscarinic Antagonists | 2008 |
Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis.
Topics: Glycopyrrolate; Humans; Hyperhidrosis; Iontophoresis | 2012 |
Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.
Topics: Adolescent; Adult; Clonidine; Cohort Studies; Drug Resistance; Female; Follow-Up Studies; Glycopyrrolate; Humans; Hyperhidrosis; Male; Muscarinic Antagonists; Retrospective Studies; Sympatholytics; Treatment Outcome; Young Adult | 2012 |
Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
Topics: Administration, Oral; Adolescent; Child; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Muscarinic Antagonists; Quality of Life; Retrospective Studies; Treatment Outcome | 2012 |
Craniofacial hyperhidrosis in post-menopausal women.
Topics: Aged; Botulinum Toxins, Type A; Face; Female; Glycopyrrolate; Humans; Hyperhidrosis; Middle Aged; Muscarinic Antagonists; Neuromuscular Agents; Postmenopause; Scalp | 2012 |
Unilateral mydriasis due to a topical "anti-sweat" preparation.
Topics: Administration, Cutaneous; Adult; Arachnoid Cysts; Comorbidity; Female; Glycopyrrolate; Humans; Hyperhidrosis; Magnetic Resonance Imaging; Muscarinic Antagonists; Mydriasis | 2013 |
Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate.
Topics: Administration, Cutaneous; Adult; Facial Dermatoses; Glycopyrrolate; Humans; Hyperhidrosis; Male; Muscarinic Antagonists | 2002 |
A unique pattern of hyperhidrosis.
Topics: Administration, Oral; Aged; Diagnosis, Differential; Glycopyrrolate; Humans; Hyperhidrosis; Male; Muscarinic Antagonists | 2006 |
Topical glycopyrrolate should not be overlooked in treatment of focal hyperhidrosis.
Topics: Administration, Cutaneous; Glycopyrrolate; Humans; Hyperhidrosis; Muscarinic Antagonists | 2006 |
Urinary retention caused by topical glycopyrrolate for hyperhidrosis.
Topics: Administration, Cutaneous; Glycopyrrolate; Humans; Hyperhidrosis; Male; Middle Aged; Muscarinic Antagonists; Urinary Retention | 2006 |
Mydriasis and accommodative failure from exposure to topical glycopyrrolate used in hyperhidrosis.
Topics: Accommodation, Ocular; Adjuvants, Anesthesia; Administration, Topical; Adult; Female; Glycopyrrolate; Humans; Hyperhidrosis; Mydriasis | 2006 |
A case of isolated axillary hyperhidrosis successfully treated topically with 1% glycopyrronium cream.
Topics: Administration, Cutaneous; Adult; Axilla; Female; Glycopyrrolate; Humans; Hyperhidrosis; Muscarinic Antagonists | 2006 |
Use of topical glycopyrrolate in Ross syndrome.
Topics: Glycopyrrolate; Humans; Hyperhidrosis; Hypohidrosis; Male; Middle Aged; Muscarinic Antagonists; Reflex, Abnormal; Syndrome; Tonic Pupil | 2006 |
Use of oral glycopyrronium bromide in hyperhidrosis.
Topics: Administration, Oral; Adult; Cholinergic Antagonists; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Retrospective Studies; Treatment Outcome | 2007 |
Dilated pupils caused by topical glycopyrrolate for hyperhidrosis.
Topics: Administration, Cutaneous; Adolescent; Female; Glycopyrrolate; Humans; Hyperhidrosis; Muscarinic Antagonists; Mydriasis | 2008 |
Oxybutynin for hyperhidrosis.
Topics: Adolescent; Adult; Depression; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Mandelic Acids; Raynaud Disease; Sympathectomy; Thoracic Nerves | 2007 |
Topical glycopyrrolate for patients with facial hyperhidrosis.
Topics: Administration, Topical; Adult; Cholinergic Antagonists; Facial Dermatoses; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Sweating | 2008 |
The use of topical glycopyrrolate in the treatment of hyperhidrosis.
Topics: Adult; Forehead; Glycopyrrolate; Humans; Hyperhidrosis; Male; Muscarinic Antagonists; Scalp Dermatoses | 1998 |
Treating hyperhidrosis. Anticholinergic drugs were not mentioned.
Topics: Adult; Cholinergic Antagonists; Contraindications; Female; Glycopyrrolate; Humans; Hyperhidrosis; Male; Middle Aged | 2000 |